ArticleAnnals of Saudi medicine

Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease.

Mohammed Hassan A Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.